Canadian medical cannabis company Plena Global Holdings said that it is preparing to begin operations in Peru as the country took a major step last week to legalize cultivation and distribution of medical cannabis.
Peru Wants to Become a Leading Country in Medical Cannabis
On February 23rd, the government of Peru published new regulations that will govern both the application and production of medical cannabis inside the country.
The publication of the regulatory decree approval establishes the legal framework for the production and management of medicinal cannabis.
The regulations will enable Peru to “position itself as a leading cultivator and supplier for the world market, while simultaneously providing effective, low cost treatment to Peruvians dealing with a broad variety of conditions,” according to a Plena Global statement.
“We want Peru to position itself as a leading country in the medicinal Cannabis industry,” Rafael Canovas Newell, Plena Global’s director of government affairs & partnerships in South America, stated. “For that to happen in our country, all steps from seed to sale must be deployed with the highest standards, the best technology, proper personnel and of course with all compliance matters in place.”
Plena Medical Cannabis Investment in Peru
Plena Global plans to begin Peruvian operations to grow cannabis in the country this year.
The company said that it will have the medical experts and processing facilities in place to start distributing medical cannabis products to hospitals and clinics as quickly as the Peruvian licensing and regulatory process will allow.
“After 18 months of collaborative work between industry and government leaders across Peru, we are excited to see the regulations published for public consultation. This is the final phase before licenses are issued and the industry begins supplying the Peruvian people with affordable medication that effectively addresses any medical conditions they need treatment for,” Plena Global CEO Richard Zwicky stated.
“We are excited to begin production in Peru, both for the local market, and for export. Allowing us to deliver low-cost, high quality medication to people in need globally,” Richard added.
